228 related articles for article (PubMed ID: 28886342)
1. A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in Fibrosis.
Ng M; Thakkar D; Southam L; Werker P; Ophoff R; Becker K; Nothnagel M; Franke A; Nürnberg P; Espirito-Santo AI; Izadi D; Hennies HC; Nanchahal J; Zeggini E; Furniss D
Am J Hum Genet; 2017 Sep; 101(3):417-427. PubMed ID: 28886342
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants.
Riesmeijer SA; Werker PMN; Nolte IM
Eur J Hum Genet; 2019 Dec; 27(12):1876-1884. PubMed ID: 31363186
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.
Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN
PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of WNT Signaling Pathway Gene Variants
Samulėnas G; Smalinskienė A; Rimdeika R; Braziulis K; Fomkinas M; Paškevičius R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573275
[TBL] [Abstract][Full Text] [Related]
5. Fibroproliferative disorders and diabetes: Understanding the pathophysiologic relationship between Peyronie's disease, Dupuytren disease and diabetes.
Gelbard MK; Rosenbloom J
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00195. PubMed ID: 33855203
[TBL] [Abstract][Full Text] [Related]
6. A shared genetic architecture between adhesive capsulitis and Dupuytren disease.
Kim SK; Khan C; Ladd AL; Tashjian RZ
J Shoulder Elbow Surg; 2023 Jan; 32(1):174-185. PubMed ID: 35987430
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
Becker K; Siegert S; Toliat MR; Du J; Casper R; Dolmans GH; Werker PM; Tinschert S; Franke A; Gieger C; Strauch K; Nothnagel M; Nürnberg P; Hennies HC;
PLoS One; 2016; 11(7):e0158101. PubMed ID: 27467239
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene.
Bayat A; Watson JS; Stanley JK; Ferguson MW; Ollier WE
Plast Reconstr Surg; 2003 Jun; 111(7):2133-9. PubMed ID: 12794452
[TBL] [Abstract][Full Text] [Related]
9. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
10. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
[TBL] [Abstract][Full Text] [Related]
11. WNT2 locus is involved in genetic susceptibility of Peyronie's disease.
Dolmans GH; Werker PM; de Jong IJ; Nijman RJ; ; Wijmenga C; Ophoff RA
J Sex Med; 2012 May; 9(5):1430-4. PubMed ID: 22489561
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
13. Dupuytren's disease therapy: targeting the vicious cycle of myofibroblasts?
Musumeci M; Vadalà G; Russo F; Pelacchi F; Lanotte A; Denaro V
Expert Opin Ther Targets; 2015; 19(12):1677-87. PubMed ID: 26690790
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue diseases: Unpicking Dupruyten disease etiology-is Wnt the way?
Bayat A
Nat Rev Rheumatol; 2011 Nov; 8(1):5-6. PubMed ID: 22083218
[No Abstract] [Full Text] [Related]
15. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
17. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
18. Dupuytren's contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development.
Kida H; Jiang JJ; Matsui Y; Takahashi I; Hasebe R; Kawamura D; Endo T; Shibayama H; Kondo M; Nishio Y; Nishida K; Matsuno Y; Oikawa T; Kubota SI; Hojyo S; Iwasaki N; Hashimoto S; Tanaka Y; Murakami M
Int Immunol; 2023 Jul; 35(7):303-312. PubMed ID: 36719100
[TBL] [Abstract][Full Text] [Related]
19. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
20. Deciphering Mesenchymal Drivers of Human Dupuytren's Disease at Single-Cell Level.
Dobie R; West CC; Henderson BEP; Wilson-Kanamori JR; Markose D; Kitto LJ; Portman JR; Beltran M; Sohrabi S; Akram AR; Ramachandran P; Yong LY; Davidson D; Henderson NC
J Invest Dermatol; 2022 Jan; 142(1):114-123.e8. PubMed ID: 34274346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
